Skip to content

Cytek Biosciences, Inc. CTKB Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$69M+1,300%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$1.95M-135%
PDF Solutions logo
PDF SolutionsPDFS
$5.21M+1.8%
HTF
Heartflow, Inc. Common StockHTFL
$3.91M+856%
Alto Neuroscience logo
Alto NeuroscienceANRO
$4.13M+144%
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets?
Cytek Biosciences, Inc. (CTKB) reported increase (decrease) in prepaid expense and other assets of -$3.85M in Q1 2026.
How has Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 2685.9% year-over-year, from $149K to -$3.85M.
What is the long-term trend for Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -19.3% compound annual growth rate (CAGR), from $6.25M to $2.66M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.